Oncology - Breast News & Articles

981 Multimodal Therapy Concept and Aerobic Training in Breast Cancer Patients With Chronic Cancer-Related Fatigue Integrative Cancer Therapies , February 7, 2013    Clinical Article

982 Androgenic pathway in triple negative invasive ductal tumours: its correlation with tumour cell proliferation Cancer Science, February 7, 2013    Clinical Article

983 Overexpression of Caveolin-1 in Cancer-Associated Fibroblasts Predicts Good Outcome in Breast Cancer Breast Care, February 7, 2013    Clinical Article

984 Sentinel Node and Recurrent Breast Cancer (SNARB): Results of a Nationwide Registration Study Annals of Surgical Oncology, February 7, 2013    Review Article

985 Incidence of diabetes among postmenopausal breast cancer survivors Diabetologia - Clinical and Experimental Diabetes and Metabolism, February 7, 2013    Review Article

986 Multicentre phase II trial of bevacizumab combined with docetaxel carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) Annals of Oncology, February 6, 2013    Clinical Article

987 Mutation analysis of the SHFM1 gene in breast/ovarian cancer families Journal of Cancer Research & Clinical Oncology, February 6, 2013    Clinical Article

988 Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study Scandinavian Journal of Gastroenterology, February 6, 2013    Review Article

989 Modern Hypofractionation Schedules for Tangential Whole Breast Irradiation Decrease the Fraction Size-corrected Dose to the Heart Clinical Oncology, February 6, 2013    Clinical Article

990 Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells Molecular Cancer Research, February 6, 2013    Clinical Article

991 Developing a theoretical framework to illustrate associations among patient satisfaction, body image and quality of life for women undergoing breast reconstruction Cancer Treatment Reviews, February 6, 2013    Clinical Article

992 The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer Full Text BMC Cancer, February 6, 2013

993 Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology Breast Cancer Research and Treatment, February 6, 2013    Clinical Article

994 Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer Breast Cancer Research and Treatment, February 6, 2013    Clinical Article

995 Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement Full Text Current Oncology, February 6, 2013    Clinical Article

996 Synergistic and Additive Effects of Modified Citrus Pectin With Two Polybotanical Compounds, in the Suppression of Invasive Behavior of Human Breast and Prostate Cancer Cells Integrative Cancer Therapies , February 6, 2013    Clinical Article

997 MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer Cancer Cell International, February 6, 2013    Clinical Article
Exclusive Author Commentary

998 Lactation pattern and the risk for hormone-related female cancer in Japan: the Ohsaki Cohort Study European Journal of Cancer Prevention, February 6, 2013    Review Article    Clinical Article

999 Filariasis of the Axilla in a Patient Returning from Travel Abroad: A Case Report Breast Care, February 6, 2013

1000 Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in China Breast Care, February 6, 2013    Clinical Article

1 Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial European Journal of Cancer, April 2, 2013

2 Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study Annals of Oncology, April 1, 2013

3 Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer British Journal of Cancer, April 16, 2013

4 Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial The Lancet Oncology, March 12, 2013

5 Association of metformin use with cancer incidence and mortality: A meta-analysis Cancer Epidemiology, April 22, 2013    Review Article

6 Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial Annals of Oncology, April 12, 2013

7 Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab: Results of the randomised GeparQuinto study (GBG 44) European Journal of Cancer, April 24, 2013

8 AVEREL: A randomized phase III trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer Journal of Clinical Oncology, April 15, 2013

9 Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study Journal of the National Cancer Institute, April 4, 2013

10 Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors Cancer, April 12, 2013

11 Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831 Cancer, April 19, 2013

12 Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments BMC Cancer, April 3, 2013    Free full text

13 Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis The Lancet Oncology, April 9, 2013    Evidence Based Medicine    Review Article

14 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

15 Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies Cancer Epidemiology, April 22, 2013    Review Article

16 Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis Annals of Oncology, April 16, 2013

17 Consensus on the regional lymph nodes irradiation in breast cancer Clinical and Translational Oncology, March 28, 2013

18 Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study The Lancet Oncology, April 19, 2013

19 Sedentary behavior, physical activity, and likelihood of breast cancer among black and white women: a report from the Southern Community Cohort Study Cancer Prevention Research, April 18, 2013

20 Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis The Lancet Oncology, March 29, 2013    Review Article